Effect of Antioxidants in Medicinal Products on Intestinal Drug Transporters
The presence of mutagenic and carcinogenic N-nitrosamine impurities in medicinal products poses a safety risk. While incorporating antioxidants in formulations is a potential mitigation strategy, concerns arise regarding their interference with drug absorption by inhibiting intestinal drug transport...
Saved in:
Main Authors: | Chetan P. Kulkarni (Author), Jia Yang (Author), Megan L. Koleske (Author), Giovanni Lara (Author), Khondoker Alam (Author), Andre Raw (Author), Bhagwant Rege (Author), Liang Zhao (Author), Dongmei Lu (Author), Lei Zhang (Author), Lawrence X. Yu (Author), Robert A. Lionberger (Author), Kathleen M. Giacomini (Author), Deanna L. Kroetz (Author), Sook Wah Yee (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers
by: Sook Wah Yee, et al.
Published: (2019) -
Role for Drug Transporters in Chemotherapy‐Induced Peripheral Neuropathy
by: Tore B. Stage, et al.
Published: (2021) -
Unveiling the Genetic Architecture of Human Disease for Precision Medicine
by: Anuradha Ramamoorthy, et al.
Published: (2019) -
Extracellular matrix control of dendritic spine and synapse structure and plasticity in adulthood
by: Aaron D Levy, et al.
Published: (2014) -
Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?
by: Christoph Wenzel, et al.
Published: (2021)